|Global head||Martha Samuelson|
|Countries with competition specialists||5|
|Continents with competition specialists||2|
|Total number of economists||886|
|% of firm specialised||37%|
|Who’s Who Legal: Competition nominees||5|
|Group one||Not disclosed|
|Group two||Not disclosed|
|Group three||Not disclosed|
|Group four||Not disclosed|
Analysis Group has an excellent reputation on both sides of the Atlantic, with competition experts in the UK, the US, Belgium, Canada and France. The formidable Martha Samuelson leads a busy global competition practice, which counts 331 specialists and in the past year worked on 32 merger control probes, 158 antitrust litigations and 32 government investigations.
On the merger control front, the firm has played a critical role in deals across multiple continents and industries including chemicals, healthcare and luxury goods. Notable highlights include advising on the acquisition of Tiffany & Co by LVMH Moët Hennessy Louis Vuitton, which was scrutinised by competition authorities in nine countries and the EU but was cleared without remedies globally. Analysis Group also assisted on Worldline’s acquisition of rival payment services and point-of-sale terminal provider Ingenico, which was approved by the European Commission, conditional on divestitures in Austria, Belgium and Luxembourg.
On the behavioural side, the group regularly advises on reverse payment litigation in the pharmaceutical sector. For example, it was instructed by counsel for Abbott, AbbVie, Barr, Duramed, Teva and their subsidiaries in the Niaspan antitrust litigation. The consultancy has also worked on numerous vertical price restraint cases, helping Kärcher and its counsel obtain dismissal of resale price maintenance claims by France’s Competition Authority, which closed the lid on a 10-year probe.
Another important category of work relates to ongoing allegations of market manipulation in the trading of financial instruments. For example, the group was retained on behalf of Rohan Ramchandani and Richard Usher, former foreign exchange traders at Citibank and JPMorgan Chase respectively, who were both accused by the US Department of the Treasury’s Office of the Comptroller of the Currency (OCC) of colluding in the forex market through a Bloomberg chatroom. Ultimately, following the depositions, the OCC withdrew all charges against Usher and Ramchandani, ending the case.
Antitrust has been a core focus of Analysis Group’s work for 40 years. From our 14 offices in the US, Canada, Europe, and Asia, we integrate industrial organization theory, industry-specific expertise, and the latest quantitative analytical methods to shed light on the conduct and market dynamics at issue in antitrust litigation, merger reviews, and market investigations. We have proven expertise in complex antitrust and competition assignments related to class certification and collective proceedings, liability, quantum of damages, pass-through, and competitive effects and optimal remedies for proposed mergers and acquisitions.
Our technical and academic experts in competition offer deep experience in a wide range of industries and markets, including high tech (hardware, software, digital platforms), media and telecommunications, financial products, health care systems, pharmaceuticals and medical devices, manufacturing, insurance, agriculture and natural resources, energy, and many others.
In particular, we have significant and ongoing involvement with multi-sided digital and transaction platform markets in North and South America, Europe, Asia, and Australia, involving competition and economic analyses for litigation support, market studies, white papers, and articles. Our work in the digital and technology sectors goes back decades and includes many of the world’s largest digital platforms, payment services, and online media companies.
The pharmaceutical industry has also been an important area of focus for our antitrust work, including high-profile matters involving allegations of delayed generic entry through reverse payment or product hopping. In other areas, we have provided economic and market analyses in some of the largest cartel cases in many different industries.
Our experts also have provided antitrust analyses and testimony in some of the most significant horizontal and vertical mergers around the world in a diverse range of industries, including multi-sided digital and transaction platforms, media and telecommunications, health care, pharmaceuticals, transportation, oil and gas, luxury and consumer goods, and retail. In merger control matters, our economists routinely:
- Evaluate potential coordinated and unilateral effects
- Define relevant markets and assess market concentration
- Analyze barriers to entry
- Estimate impacts on efficiencies, innovation, labor, and other market factors
- Support the design of optimal remedies
Alongside our antitrust and competition work, we provide expertise in economics, finance, intellectual property, health care analytics, and strategy to top law firms, Fortune 500 companies, and government agencies. Drawing on our global network of internal experts and affiliated experts from academia, industry, and government, we offer our clients exceptional depth of analysis.